Literature DB >> 5667981

Management of endocrine ophthalmopathy.

.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5667981      PMCID: PMC1991119     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.

Authors:  J P KRISS; V PLESHAKOV; J R CHIEN
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

2.  THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.

Authors:  A PINCHERA; M G PINCHERA; J B STANBURY
Journal:  J Clin Endocrinol Metab       Date:  1965-02       Impact factor: 5.958

3.  Prednisone therapy in ophthalmic Graves' disease.

Authors:  W H EVANS
Journal:  Trans Ophthalmol Soc U K       Date:  1961

4.  Depot-methylprednisolone for subconjunctival and retrobulbar injections.

Authors:  S GEBERTT
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

5.  The use of ACTH and cortisone in the treatment and in the differential diagnosis of malignant exophthalmos.

Authors:  L W KINSELL; J W PARTRIDGE; N FOREMAN
Journal:  Ann Intern Med       Date:  1953-05       Impact factor: 25.391

6.  Adrenergic blockade and the eye signs of thyrotoxicosis.

Authors:  J M Sneddon; P Turner
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

7.  Topical guanethidine therapy for endocrine lid retraction.

Authors:  A J Gay; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1966-09

8.  Topical sympatholytic therapy for pathologic lid retraction.

Authors:  A J Gay; M L Salmon; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1967-03

9.  Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

Authors:  L M Lipman; D E Green; N J Snyder; J C Nelson; D H Solomon
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

10.  GUANETHIDINE AND PUPILLARY REACTION.

Authors:  W DORIAN; K E SCHIRMER
Journal:  Can Med Assoc J       Date:  1964-04-11       Impact factor: 8.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.